Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 4, 1998, Pages 1601-1606

  Ye, Keqiang ^a   Ke, Yong ^a   Keshava, Nagalakshmi ^a   Shanks, John ^a   Kapp, Judith A ^a   Tekmal, Rajeshwar R ^a   Petros, John ^a   Joshi, Harish C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NOSCAPINE; OPIATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DEATH; CELL DIVISION; CHROMOSOME DUPLICATION; GENETIC STABILITY; LYMPHATIC SYSTEM TUMOR; METAPHASE; MITOSIS SPINDLE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DNA FRAGMENTATION; FEMALE; HELA CELLS; HUMANS; METAPHASE; MICE; MICE, INBRED C57BL; MICROTUBULES; NOSCAPINE; PROTEIN CONFORMATION; THYMOMA; TUBULIN;

ANIMALIA; MAMMALIA; MURINAE; MUS MUSCULUS;

EID: 0032539565     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.4.1601     Document Type: Article

References (27)

1. Hartwell, L. H. & Weinert, T. A. (1989) Science 246, 629-634.
2. Murray, A. W. (1994) Curr. Opin. Cell Biol. 6, 872-876.
3. White, E. (1996) Genes Dev. 10, 1-5.
4. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z. & Kolesnick, R. (1995) Cell 82, 405-414.
5. Epstein, R. J. (1990) J. Clin. Oncol. 8, 2062-2084.
6. Rowinsky, E. K. & Donehower, R. C. (1991) Pharmacol. Ther. 52, 35-84.
7. Empey, D. W., Laitinen, L. A., Young, G. A., Bye, C. E. & Hughes, D. T. D. (1979) Eur. J. Clin. Pharmacol. 16, 393-397.
8. Dahlstrom, B., Mellstrand, T., Lofdahl, C. G. & Johansson, M. (1982) Eur. J. Clin. Pharmacol. 22, 535-539.
9. Karlsson, M. O., Dahlstrom, B., Eckernas, S. A., Johansson, M. & Alm, A. T. (1990) Eur. J. Clin. Pharmacol. 39, 275-279.
10. Karlsson M. O., Dahlstrom, B. & Neil, A. (1988) Eur. J. Pharmacol. 145, 195-203.
11. Mourey, R. J., Dawson, T. M., Barrow, R. K., Enna, A. E. & Snyder, S. H. (1992) Mol. Pharmacol. 42, 619-626.
12. Mitchell, I. D., Carlton, J. B., Chan, M. Y. W., Robinson, A. & Sunderland, J. (1991) Mutagenesis 6, 479-486.
13. Gatehouse, D. G., Stemp, G., Pascoe, S., Wilcox, P., Hawker, J. & Tweats, D. J. (1991) Mutagenesis 6, 279-283.
14. Tsunoda, N. & Yoshimuda, H. (1979) Xenobiotica 9, 181-187.
15. Haikala, V., Sothmann, A. & Marvola, M. (1986) Eur. J. Clin. Pharmacol. 31, 367-369.
16. Moore, M. W., Carbone, F. R. & Bevan, M. J. (1988) Cell 54, 777-785.
17. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P. & Traganos, F. (1992) Cytometry 13, 795-808.
18. Walton, M. L, Whysong, D., O'Connor, P. M., Hockenbery, D., Korsmeyer, S. J. & Kohn, K. W. (1993) Cancer Res. 53, 1853-1861.
19. Gorczyca, W., Gong, J. & Darzynkiewicz, Z. (1993) Cancer Res. 53, 1945-1951.
20. Peyrot, V., Leynadier, D., Sarrazin, M., Briand, C., Menendez, M., Laynez, J. & Andreu, J. M. (1992) Biochemistry 31, 11125-11132.
21. O'Brien, E. T., Jacobs, R. S. & Wilson, L. (1983) Mol. Pharmacol. 24, 493-499.
22. Lasagna, L., Owens, A. H., Shnider, B. I. & Gold, G. L. (1961) Cancer Chemother. Rep. 15, 33-34.
23. Schiff, P. B., Fant, J. & Horwitz, S. B. (1979) Nature (London) 277, 665-667.
24. Kalechman, Y., Shani, A., Dovrat, S., Whisnant, J. K., Mettinger, K., Albeck, M. & Sredni, B. (1996) J. Immunol. 156, 1101-1109.
25. Schiff, P. B. & Horwitz, S. B. (1980) Proc. Natl. Acad. Sci. USA 77, 1561-1565.
26. Wilson, L. & Jordan, M. A. (1995) Chem. Biol. 2, 569-573.
27. Kavanagh, J. J & Kudelka, A. P. (1993) Curr. Opin. Oncol. 5, 891-899.